Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.

Toward a Computable Phenotype for Determining Eligibility of Lung Cancer Screening Using Electronic Health Records Accurate human leukocyte antigen (HLA) typing is an essential step for designing ...

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an extension of its previously ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) ...

Researchers have harnessed the power of artificial intelligence to design a blueprint for building a vaccine that aims to ...

Most people think of vaccines as being "preventive," and taken to "prevent or lessen the impact of certain infectious ...

Explore the evolving landscape of over 60 mRNA cancer vaccines progressing in clinical trials globally. Highlights include key biopharma collaborations, innovative proprietary technologies ...

Explore the evolving landscape of over 60 mRNA cancer vaccines progressing in clinical trials globally. Highlights include key biopharma collaboratio ...

Explore the evolving landscape of over 60 mRNA cancer vaccines progressing in clinical trials globally. Highlights include key biopharma collaborations, innovative proprietary technologies, ...